Willey J - Search Results

1

Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer.

Ibrahim NK, Valero V, Theriault RL, Willey J, Walters RS, Buzdar AU, Booser DJ, Hortobagyi GN. Ibrahim NK, et al. Among authors: willey j. Am J Clin Oncol. 2000 Apr;23(2):117-21. doi: 10.1097/00000421-200004000-00003. Am J Clin Oncol. 2000. PMID: 10776969 Clinical Trial.

2

Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer.

Holmes FA, Madden T, Newman RA, Valero V, Theriault RL, Fraschini G, Walters RS, Booser DJ, Buzdar AU, Willey J, Hortobagyi GN. Holmes FA, et al. Among authors: willey j. J Clin Oncol. 1996 Oct;14(10):2713-21. doi: 10.1200/JCO.1996.14.10.2713. J Clin Oncol. 1996. PMID: 8874332 Clinical Trial.

3

Prospective assessment of cardiac toxicity during a randomized phase II trial of doxorubicin and paclitaxel in metastatic breast cancer.

Hortobagyi GN, Willey J, Rahman Z, Holmes FA, Theriault RL, Buzdar AU. Hortobagyi GN, et al. Among authors: willey j. Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-65-S17-68. Semin Oncol. 1997. PMID: 9374097 Clinical Trial.

4

Hand-foot syndrome following prolonged infusion of high doses of vinorelbine.

Hoff PM, Valero V, Ibrahim N, Willey J, Hortobagyi GN. Hoff PM, et al. Among authors: willey j. Cancer. 1998 Mar 1;82(5):965-9. doi: 10.1002/(sici)1097-0142(19980301)82:5<965::aid-cncr23>3.0.co;2-y. Cancer. 1998. PMID: 9486588 Clinical Trial.

5

Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer.

Valero V, Buzdar AU, Theriault RL, Azarnia N, Fonseca GA, Willey J, Ewer M, Walters RS, Mackay B, Podoloff D, Booser D, Lee LW, Hortobagyi GN. Valero V, et al. Among authors: willey j. J Clin Oncol. 1999 May;17(5):1425-34. doi: 10.1200/JCO.1999.17.5.1425. J Clin Oncol. 1999. PMID: 10334527 Clinical Trial.

6

Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results.

Holmes FA, Valero V, Walters RS, Theriault RL, Booser DJ, Gibbs H, Fraschini G, Buzdar AU, Willey J, Frye D, Asmar L, Hortobagyi GN. Holmes FA, et al. Among authors: willey j. Ann Oncol. 1999 Apr;10(4):403-11. doi: 10.1023/a:1008360406322. Ann Oncol. 1999. PMID: 10370782 Free article. Clinical Trial.

7

Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.

Ibrahim NK, Rahman Z, Valero V, Willey J, Theriault RL, Buzdar AU, Murray JL 3rd, Bast R, Hortobagyi GN. Ibrahim NK, et al. Among authors: willey j. Cancer. 1999 Oct 1;86(7):1251-7. doi: 10.1002/(sici)1097-0142(19991001)86:7<1251::aid-cncr21>3.0.co;2-f. Cancer. 1999. PMID: 10506711 Clinical Trial.

8

Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma.

Ibrahim NK, Buzdar AU, Valero V, Dhingra K, Willey J, Hortobagyi GN. Ibrahim NK, et al. Among authors: willey j. Cancer. 2001 Feb 15;91(4):664-71. Cancer. 2001. PMID: 11241232 Clinical Trial.

9

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial.

Hortobagyi GN, Ueno NT, Xia W, Zhang S, Wolf JK, Putnam JB, Weiden PL, Willey JS, Carey M, Branham DL, Payne JY, Tucker SD, Bartholomeusz C, Kilbourn RG, De Jager RL, Sneige N, Katz RL, Anklesaria P, Ibrahim NK, Murray JL, Theriault RL, Valero V, Gershenson DM, Bevers MW, Huang L, Lopez-Berestein G, Hung MC. Hortobagyi GN, et al. Among authors: willey js. J Clin Oncol. 2001 Jul 15;19(14):3422-33. doi: 10.1200/JCO.2001.19.14.3422. J Clin Oncol. 2001. PMID: 11454891 Clinical Trial.

10

Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation.

Ibrahim NK, Valero V, Rahman Z, Theriault RL, Walters RS, Buzdar AU, Booser DJ, Holmes FA, Murray JL 3rd, Willey J, Bast R, Hortobagyi GN. Ibrahim NK, et al. Among authors: willey j. Cancer Invest. 2001;19(5):459-66. doi: 10.1081/cnv-100103844. Cancer Invest. 2001. PMID: 11458813 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

575 results

Search Page

Filters